Pulmonx Corporation (LUNG) vs MediciNova, Inc. (MNOV)
A side-by-side comparison of Pulmonx Corporation and MediciNova, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LUNG
Pulmonx Corporation
$1.89HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT
MNOV
MediciNova, Inc.
$1.68HealthcareDelayed quote: Oct 6, 2026, 12:08 PM EDT
Total return — LUNG vs MNOV
growth of $100 · dividends reinvested · last 6yLUNG -95.2% (-39.8%/yr)MNOV -65.6% (-16.3%/yr)MNOV compounded faster over this window
Log scale — wide-divergence pair
LUNG MNOV
LUNG vs MNOV: by the numbers
- •MNOV is the larger company ($82M vs $80M market cap).
- •Both run net losses; LUNG's is the smaller (-55.03% vs -1168.20% net margin).
- •LUNG grew revenue faster over the past five years (15.86% vs -25.46% CAGR).
Metrics side by side
Valuation
| Metric | LUNG | MNOV |
|---|---|---|
| P/S ratio | 0.91 | 89.57 |
| P/B ratio | 2.04 | 2.21 |
Profitability
| Metric | LUNG | MNOV |
|---|---|---|
| Gross margin | 77.06% | 7.58% |
| Operating margin | -52.96% | -3242.47% |
| Net margin | -55.03% | -1168.20% |
| ROE | -122.76% | -28.85% |
| ROIC | -48.39% | -31.62% |
Growth (annualized)
| Metric | LUNG | MNOV |
|---|---|---|
| Revenue CAGR (5Y) | 15.86% | -25.46% |
| Total return CAGR (5Y) | -45.30% | -13.62% |
Frequently asked
- Which has grown faster, LUNG or MNOV?
- Over the past five years, LUNG grew revenue faster — LUNG at a 15.86% CAGR versus MNOV at -25.46%.
- How have LUNG and MNOV total returns compared?
- Over the past 5 years, LUNG delivered -45.30% and MNOV delivered -13.62% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Pulmonx ROEMediciNova ROEPulmonx operating marginMediciNova operating marginPulmonx revenue growthMediciNova revenue growthPulmonx free cash flowMediciNova free cash flow
Pulmonx & MediciNova appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.